
Who's Lobbying for Whom: AbbVie Corp. wants to talk access to medicines
The company was registered this past week by Ashley Millman, a consultant with McMillan Vantage, as well as in-house by Rami Fayed, AbbVie's general manager and vice president.
The bill, which received royal assent but has not yet been proclaimed into force, makes it a provincial offence for landlords to “knowingly permit” drug production or trafficking on their property. A first offence could cost up to $250,000, and jail time would also be possible. But how could a landlord possibly know what is going on inside a privately rented unit?
In a letter addressed to Prime Minister Mark Carney, they argue that current EV mandates could trigger plant closures, threaten tens of thousands of jobs, and drive away future investment.
“Instead of being enforcers, council members have become enablers of bad behaviour because of the politicized nature of the process,” said John Mascarin, a municipal law expert who has acted as an integrity commissioner in several Ontario cities.
The comments mark a reversal from Ford’s declaration last week that Ontario would use its constitutional powers to issue its own permits to asylum seekers in response to federal delays.
Coca-Cola Canada Bottling Limited was registered by Laryssa Waler-Hetmanczuk and Mathew Clancy, both consultants with Henley Strategies, as well as by Luis Lopez Guzman and Patrick Lavelle-Tuns, consultants from Endgame Strategies.